https://scholars.lib.ntu.edu.tw/handle/123456789/413438
標題: | Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ER£\-£_Np63-Integrin £]4 Signaling Pathway | 作者: | Ho J.-Y. Chang F.-W. Huang F.S. Liu J.-M. Liu Y.-P. Chen S.-P. Liu Y.-L. Cheng K.-C. Yu C.-P. KUAN-CHEN CHENG |
公開日期: | 2016 | 卷: | 11 | 期: | 2 | 來源出版物: | PLoS ONE | 摘要: | Estrogen induces ER£\-positive breast cancer aggressiveness via the promotion of cell proliferation and survival, the epithelial-mesenchymal transition, and stem-like properties. Integrin £]4 signaling has been implicated in estrogen/ER£\-induced tumorigenicity and antiapoptosis; however, this signaling cascade poorly understood. £_Np63, an N-terminally truncated isoform of the p63 transcription factor, functions as a transcription factor of integrin£]4 and therefore regulates cellular adhesion and survival. Therefore, the aim of the present study was to investigate the estrogen-induced interaction between ER£\, £_Np63 and integrin £]4 in breast cancer cells. In ER£\-positive MCF-7 cells, estrogen activated ER£\ transcription, which induced £_Np63 expression. And £_Np63 subsequently induced integrin £]4 expression, which resulted in AKT phosphorylation and enhanced cell viability and motility. Conversely, there was no inductive effect of estrogen on £_Np63-integrin£]4-AKT signaling or on cell viability and motility in ER£\-negative MDA-MB-231 cells. £_Np63 knockdown abolishes these estrogen-induced effects and reduces cell viability and motility in MCF-7 cells. Nevertheless, £_Np63 knockdown also inhibited cell migration in MDA-MB-231 cells through reducing integrin £]4 expression and AKT phosphorylation. In conclusion, estrogen enhances ER£\-positive breast cancer cell viability and motility through activating the ER£\- £_Np63-integrin £]4 signaling pathway to induce AKT phosphorylated activation. Those findings should be useful to elucidate the crosstalk between estrogen/ER signaling and £_Np63 signaling and provide novel insights into the effects of estrogen on breast cancer progression. ? 2016 Ho et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/413438 | ISSN: | 19326203 | DOI: | 10.1371/journal.pone.0148301 https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959010802&doi=10.1371%2fjournal.pone.0148301&partnerID=40&md5=f1cd9aa3cd54166d4665af29b24ebab9 |
SDG/關鍵字: | beta4 integrin; delta np63 protein; estrogen; estrogen receptor alpha; protein kinase B; protein p63; unclassified drug; beta4 integrin; estrogen; estrogen receptor alpha; estrogen receptor alpha, human; small interfering RNA; TP63 protein, human; transcription factor; tumor suppressor protein; Article; breast cancer; breast carcinogenesis; cancer growth; cell adhesion; cell migration; cell motility; cell survival; cell viability; controlled study; enzyme activation; human; protein expression; protein phosphorylation; protein protein interaction; signal transduction; biosynthesis; breast tumor; cell motion; cell proliferation; drug effects; female; genetics; MCF-7 cell line; metabolism; pathology; phosphorylation; RNA interference; signal transduction; tumor cell line; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Estrogen Receptor alpha; Estrogens; Female; Humans; Integrin beta4; MCF-7 Cells; Phosphorylation; RNA Interference; RNA, Small Interfering; Signal Transduction; Transcription Factors; Tumor Suppressor Proteins |
顯示於: | 生物科技研究所 |
檔案 | 描述 | 大小 | 格式 | |
---|---|---|---|---|
journal.pone.0148301.PDF | 3.38 MB | Adobe PDF | 檢視/開啟 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。